Cell therapy drug - List of Manufacturers, Suppliers, Companies and Products | IPROS GMS

[Market Report] Global CAR-T Cell Therapy Market

Global CAR-T Cell Therapy Market: A Pioneer in the Fight Against Cancer, Expected to Reach 5.9 Billion USD by 2031

The global CAR T cell therapy market is at the forefront of the fight against cancer, providing innovative and promising treatment options for patients. According to recent market reports, the global CAR T cell therapy market generated approximately $1.9 billion in revenue in 2022, and it is estimated to surge to $5.9 billion by 2031. This remarkable growth trajectory is projected to have a steady annual compound growth rate (CAGR) of 13.5% from 2023 to 2031. Chimeric Antigen Receptor (CAR) T cell therapy is a groundbreaking form of gene cell therapy that utilizes the body's T cells to target and eliminate cancer cells. Typically, the treatment involves three key steps: genetic modification of T cells, infusion of CAR T cells into the patient's body, and collection of T cells, all working together to combat cancer. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.